Evidence map›Paper›PMID 32038549›Full record

ArticleFrontiers in microbiology2019

Joseph P Hoffmann, Jessica K Friedman, Yihui Wang, James B McLachlan, Mimi C Sammarco, Lisa A Morici, Chad J Roy

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Biofilm · 2023
    Article
  4. Article
  5. Healing wounds, defeating biofilms:Frontiers in microbiology · 2023
    Article
  6. Sprayed PAA-CaORegenerative biomaterials · 2023
    Article
  7. Article
  8. "Universal" Antimicrobial Combination of Bacitracin and HisInternational journal of molecular sciences · 2022
    Article
  9. Mechanistic Studies andJournal of medicinal chemistry · 2022
    Article
  10. Article
  11. Pharmacological Mechanisms of Shangke Huangshui against Skin and Soft Tissue Infection.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Speciality Grand Challenge for "Biofilms".Frontiers in cellular and infection microbiology · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joseph P HoffmannDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
Jessica K FriedmanDepartment of Surgery, Tulane University School of Medicine, New Orleans, LA, United States.
Yihui WangDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
James B McLachlanDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
Mimi C SammarcoDepartment of Surgery, Tulane University School of Medicine, New Orleans, LA, United States.
Lisa A MoriciDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
Chad J RoyDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States.
Tulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
NIGMS NIH HHS U54 GM104940NIH HHS P51 OD011104
6 · The paper itself

Abstract

Increased prevalence of antibiotic resistance in skin and soft tissue infections is a concerning public health challenge currently facing medical science. A combinatory, broad spectrum biocidal antiseptic has been developed ("ASP") as a topically applied solution to potential resistant and polymicrobial infected wounds that may be encountered in this context. The ASP-105 designate was evaluated

Indexed as

antimicrobialluminescentmicrobiocideStaphylococcus aureuswound healingwound infection

Identifiers

PMID32038549
PMCPMC6990143
OpenAlexW3001026379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.